Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Cell Death & Disease
|
September 14, 2022
Targeting of MCL-1 in breast cancer-associated fibroblasts reverses their myofibroblastic phenotype and pro-invasive properties
Thomas L Bonneaud, Chloé C Lefebvre, Lisa Nocquet, et al.
Breast Cancer (Tokyo, Japan)
|
May 22, 2024
Mesenchymal-like immune-altered is the fourth robust triple-negative breast cancer molecular subtype
Pascal Jézéquel, Hamza Lasla, Wilfried Gouraud, et al.
Computers in Biology and Medicine
|
December 14, 2020
Development of an absolute assignment predictor for triple-negative breast cancer subtyping using machine learning approaches
Fadoua Ben Azzouz, Bertrand Michel, Hamza Lasla, et al.
Cell Death & Disease
|
August 9, 2025
MCL-1 as a molecular switch between myofibroblastic and pro-angiogenic features of breast cancer-associated fibroblasts
Chloé C Lefebvre, Philippine Giowachini, Jennifer Derrien, et al.
EMBO Reports
|
December 14, 2017
E2F1 interacts with BCL-xL and regulates its subcellular localization dynamics to trigger cell death
Céline Vuillier, Steven Lohard, Aurélie Fétiveau, et al.
Cell Reports
|
December 24, 2016
Tight Sequestration of BH3 Proteins by BCL-xL at Subcellular Membranes Contributes to Apoptotic Resistance
Jessie Pécot, Laurent Maillet, Janic Le Pen, et al.
Trends in Genetics : TIG
|
June 4, 2026
Emerging role of G-quadruplexes in alternative splicing regulation
Aline Peynet, Ronan Le Sénéchal, Marc Keruzoré, et al.
Oncogene
|
February 3, 2018
The oncogenic tyrosine kinase Lyn impairs the pro-apoptotic function of Bim
Lazaro E Aira, Elodie Villa, Pascal Colosetti, et al.
Nature Communications
|
January 16, 2020
STING-dependent paracriny shapes apoptotic priming of breast tumors in response to anti-mitotic treatment
Steven Lohard, Nathalie Bourgeois, Laurent Maillet, et al.
EMBO Molecular Medicine
|
August 26, 2025
EMT-ciliary signaling in quasi-mesenchymal-stem-like cells drives therapeutic resistance and is a druggable vulnerability in triple-negative breast cancer
Camille E Tessier, Jennifer Derrien, Aurore M M Dupuy, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Cell Death & Disease
|
September 14, 2022
Targeting of MCL-1 in breast cancer-associated fibroblasts reverses their myofibroblastic phenotype and pro-invasive properties
Thomas L Bonneaud, Chloé C Lefebvre, Lisa Nocquet, et al.
Breast Cancer (Tokyo, Japan)
|
May 22, 2024
Mesenchymal-like immune-altered is the fourth robust triple-negative breast cancer molecular subtype
Pascal Jézéquel, Hamza Lasla, Wilfried Gouraud, et al.
Computers in Biology and Medicine
|
December 14, 2020
Development of an absolute assignment predictor for triple-negative breast cancer subtyping using machine learning approaches
Fadoua Ben Azzouz, Bertrand Michel, Hamza Lasla, et al.
Cell Death & Disease
|
August 9, 2025
MCL-1 as a molecular switch between myofibroblastic and pro-angiogenic features of breast cancer-associated fibroblasts
Chloé C Lefebvre, Philippine Giowachini, Jennifer Derrien, et al.
EMBO Reports
|
December 14, 2017
E2F1 interacts with BCL-xL and regulates its subcellular localization dynamics to trigger cell death
Céline Vuillier, Steven Lohard, Aurélie Fétiveau, et al.
Cell Reports
|
December 24, 2016
Tight Sequestration of BH3 Proteins by BCL-xL at Subcellular Membranes Contributes to Apoptotic Resistance
Jessie Pécot, Laurent Maillet, Janic Le Pen, et al.
Trends in Genetics : TIG
|
June 4, 2026
Emerging role of G-quadruplexes in alternative splicing regulation
Aline Peynet, Ronan Le Sénéchal, Marc Keruzoré, et al.
Oncogene
|
February 3, 2018
The oncogenic tyrosine kinase Lyn impairs the pro-apoptotic function of Bim
Lazaro E Aira, Elodie Villa, Pascal Colosetti, et al.
Nature Communications
|
January 16, 2020
STING-dependent paracriny shapes apoptotic priming of breast tumors in response to anti-mitotic treatment
Steven Lohard, Nathalie Bourgeois, Laurent Maillet, et al.
EMBO Molecular Medicine
|
August 26, 2025
EMT-ciliary signaling in quasi-mesenchymal-stem-like cells drives therapeutic resistance and is a druggable vulnerability in triple-negative breast cancer
Camille E Tessier, Jennifer Derrien, Aurore M M Dupuy, et al.
Page
of 3